Canada will cut prices but avoid tenders

 
• By David Wallace
  
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Drug Pricing

More from Policy & Regulation